SoftOx Solutions AS ( (DE:6FV) ) has issued an update.
SoftOx Solutions AS has announced a private placement agreement to issue new shares, aiming to raise approximately NOK 9,054,500. The proceeds will address short-term working capital needs and support the company’s strategic objectives, including clinical trials for VAP indication. The placement, subject to board approval, involves a deviation from shareholders’ preferential rights to expedite funding and reduce transaction risks, with future opportunities for shareholder participation.
More about SoftOx Solutions AS
SoftOx Solutions AS operates in the healthcare industry, focusing on developing innovative solutions for infection control and wound care. The company is involved in clinical trials and aims to enhance its market position through strategic funding initiatives.
Technical Sentiment Signal: Buy
Current Market Cap: €12.83M
For a thorough assessment of 6FV stock, go to TipRanks’ Stock Analysis page.